ENVUE MEDICAL INC NEW
FEED
FEED was delisted on the 15th of September, 2026.
6 hedge funds and large institutions have $906K invested in ENVUE MEDICAL INC NEW in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
1.36% less ownership
Funds ownership: 6.53% → 5.17% (-1.4%)
33% less funds holding
Funds holding: 9 → 6 (-3)
57% less capital invested
Capital invested by funds: $2.12M → $906K (-$1.21M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$18.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$151K |
| 2 |
Renaissance Technologies
New York
|
-$114K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$45K |
| 4 |
Millennium Management
New York
|
-$35K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8K |
FEED Hedge Fund Activity: Q2 2022 in Review
6 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q2 2022, worth a combined $906K — down 57% from $2.12M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of FEED and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Geode Capital Management, adding an estimated $18.9K. The largest seller was Citadel Advisors, exiting entirely with an estimated $151K sold.
- 6 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q2 2022, down from 9 in Q1 2022.
- Funds reported $906K of ENVUE MEDICAL INC NEW stock for Q2 2022, down 57% quarter-over-quarter.
- 0 funds opened new ENVUE MEDICAL INC NEW positions in Q2 2022 and 3 closed out, a net change of -3 holders.
- The largest ENVUE MEDICAL INC NEW buyer in Q2 2022 was Geode Capital Management, an estimated $18.9K added.
- The largest ENVUE MEDICAL INC NEW seller in Q2 2022 was Citadel Advisors, an estimated $151K sold.
Based on aggregated 13F filings for Q2 2022.